Brokerage App For Android Devices

New Post Public Reply Private Reply Replies (0) Message Board
Langan
Are you looking for a Brokerage android device app? Check out the Investors Hangout app. Many options and features to choose from but still very simple to use.

https://play.google.com/store/apps/details?id...&hl=en

More about the Investors Hangout app.

Investors Hangout app allows you to access the stock message boards, stock quotes and stocks charts for all major stock exchanges.

Categories Include:
• General Disscusion Forums
• American Stock Exchange
• NASDAQ Stock Exchange
• New York Stock Exchange
• OTCBB, Pink Sheets and Penny Stocks
• Australian Securities Exchange
• Euronext Amsterdam
• Euronext Brussels
• Euronext Lisbon
• Euronext Paris
• Foreign Exchange FOREX
• Hong Kong Stock Exchange
• London Stock Exchange
• Milan Stock Exchange
• New Zealand Exchange
• Singapore Stock Exchange
• Toronto Stock Exchange

There's absolutely no other stock message forum app like this in the World. It functions in real-time with the live site (investorshangout.com), a website with over 38,000 boards, thousands of community minded daily users, RSS Capabilities with social sharing tools that make sharing on Google+, Facebook, and Twitter very simple. It's free, fast, and extremely versatile!

With social media on the rise, this niche site has a large growing user base that evolves on trust. Whether your a publicly traded company's IR interested in reaching a large investor platform or an investor looking to discover the next big thing, you can rest assured that the sites staff/owners do not trade.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Current Market Sentiment on HealthEquity Shares: A Closer Look

Updated Category News Views 113

Understanding HealthEquity's Short Interest Dynamics HealthEquity Inc (NYSE: HQY) has seen a significant decrease in its short percent of float, which recently dropped by 11.68%. As of the last report, the company had approximately 5.26 million shares sold short, representing 7.03% of its regular shares available for trading. This situation also highlights an average...

Continue Reading
Investors Update: Class Action Against Bumble Inc. Soon

Updated Category News Views 104

Update on Class Action Lawsuit Against Bumble Inc. (BMBL) The Law Offices of Frank R. Cruz are reminding investors about an upcoming significant deadline concerning a class action lawsuit against Bumble Inc. This lawsuit affects investors who acquired BMBL securities during the designated Class Period. Understanding the Class Action Lawsuit The class action was initiated...

Continue Reading
Analysis of Williams-Sonoma's Recent Surge and Current Changes

Updated Category News Views 293

Understanding Williams-Sonoma's Recent Stock Movements This week has seen an impressive rise of nearly 30% in shares of Williams-Sonoma, Inc. (NYSE: WSM), but recent trading indicates a slight pullback. Investors are reacting to two key factors: the natural tendency to take profits and the decision of some buyers to exit losing positions as market conditions evolve. The...

Continue Reading
Understanding the Arconic Corporation Class Action Update

Updated Category News Views 139

Overview of the Class Action Lawsuit Against Arconic Corporation Levi & Korsinsky, LLP has recently announced a class action regarding Arconic Corporation (ARNC). This situation affects investors who may have been impacted by alleged securities fraud. The firm aims to represent those who traded Arconic shares during a specified period and seeks to recover losses resulting...

Continue Reading
Cambrex Partners with Lilly to Enhance Biotech Innovations

Updated Category News Views 220

Cambrex's Strategic Collaboration with Eli Lilly Cambrex, a key player in the global contract development and manufacturing organization (CDMO) sector, has announced an exciting new partnership with Eli Lilly and Company to enhance support for biotech collaborators. Through this agreement, Cambrex aims to provide accelerated access to essential clinical development...

Continue Reading